Berry Genomics Co.,Ltd

Equities

000710

CNE000000PN7

Healthcare Facilities & Services

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-04-29 pm EDT			5-day change	1st Jan Change
8.7 ^CNY	+1.40%		+23.93%	-24.48%

Apr. 24	Berry Genomics Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 24	Berry Genomics Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Berry Genomics Co.,Ltd cancelled the transaction announced on August 13, 2020

February 24, 2021

On February 25, 2021, Berry Genomics Co.,Ltd (SZSE:000710) cancelled the transaction. The cancellation has been approved by the board of directors in its 6th Meeting of the 9th Directorate and the 5th Meeting of the 9th Supervisory Board.

Latest news about Berry Genomics Co.,Ltd

Berry Genomics Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 24	CI
Berry Genomics Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 24	CI
Berry Genomics to Sell Fujian Industrial Park Assets to New JV	Feb. 05	MT
Berry Genomics Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-27	CI
Berry Genomics's Controlling Shareholder Plans to Unload up to 4% Company Stakes	23-08-21	CI
Huang Qiwei cancelled the acquisition of a 3.81% stake in Berry Genomics Co.,Ltd from Gao Yang and Hou Ying.	23-08-20	CI
Berry Genomics Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-15	CI
Berry Genomics Co.,Ltd Announces Executive Appointments	23-08-07	CI
Berry Genomics Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-28	CI
Huang Qiwei agreed to acquire a 3.81% stake in Berry Genomics Co.,Ltd from Gao Yang and Hou Ying for approximately CNY 160 million.	23-04-16	CI
Berry Genomics Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-07	CI
Berry Genomics Co.,Ltd(XSEC:000710) dropped from S&P Global BMI Index	22-12-19	CI
Berry Genomics Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-28	CI
Berry Genomics Appoints New CFO	22-09-12	MT
Berry Genomics Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-12	CI
Berry Genomics Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-14	CI
Berry Genomics Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-14	CI
PacBio and Berry Genomics Announces Collaboration to Bring Long Read Desktop Sequencing Instrument to the Clinical Market in China	22-01-11	CI
Wang Tianyi agreed to acquire 2.6226% in Berry Genomics Co.,Ltd from Gao Yang and Hou Ying for CNY 130 million.	22-01-05	CI
Berry Genomics Co.,Ltd(SZSE:000710) dropped from Shenzhen Stock Exchange Component Index	21-12-10	CI
Berry Genomics Co.,Ltd(SZSE:000710) dropped from Shenzhen Stock Exchange Component A Share Index	21-12-10	CI
Berry Genomics Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2021	21-10-29	CI
Berry Genomics Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2021	21-08-29	CI
Alibaba Health Information Technology : , Berry Genomics to Build Early Cancer Screening System	21-06-21	MT
Berry Genomics Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2021	21-04-28	CI

Chart Berry Genomics Co.,Ltd

Duration

Period

More charts

Company Profile

Berry Genomics Co Ltd is a company mainly engaged in medical testing related services. The Company's business is comprised of basic scientific research services, medical testing services, testing reagent sales and testing equipment sales. The basic scientific research services business provides the clients with multiple sequencing platforms for testing projects, such as transcriptome sequencing, human whole exome sequencing and whole genome sequencing. The medical testing services business include tumor genetic testing services, genetic disease genetic testing services and reproductive health testing services. The Company sells a range of reagents and equipment, including NextSeq CN500 gene sequencer and general reagents for sequencing reactions.

Sector

Healthcare Facilities & Services

Calendar

2024-05-17 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Medical & Diagnostic Laboratories

	1st Jan change	Capi.
BERRY GENOMICS CO.,LTD	-24.48%	425M
SONIC HEALTHCARE LIMITED	-19.14%	8.22B
RADNET, INC.	+48.03%	3.73B
SYNLAB AG	-8.06%	2.46B
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.	-38.71%	2.46B
DR. LAL PATHLABS LIMITED	-8.84%	2.36B
NEOGENOMICS, INC.	-10.26%	1.78B
FLEURY S.A.	-19.01%	1.52B
DIAN DIAGNOSTICS GROUP CO.,LTD.	-40.78%	1.21B
METROPOLIS HEALTHCARE LIMITED	+8.32%	1.12B

Medical & Diagnostic Laboratories